SPDR S&P China

Ping An Shareholders Meeting: Guo Xiaotao Reveals New Channel and Product Balance Strategy for Life Insurance Growth

Alibaba's Joe Tsai and Eddie Wu Letter: AI Business Enters Commercialization, Projecting 30 Billion Annual Revenue

JD Announces Operation of National First Embodied AI Data Collection Community in Suqian

Ping An Insurance increases stake in China Life by approx. 1.68 billion HKD on May 18, holding ratio rises to 15.13%

Ping An announces adjustment of conversion prices for two convertible bonds, effective June 10

BOCOM International Cuts Xiaomi Target Price to 34.8 HKD, Expects Q1 Adjusted Net Profit to Drop 6% QoQ

Ping An Increases Holding in Agricultural Bank of China H-Shares, Total Stake Exceeds 25%

Alibaba Cloud Announces Full Openness of Bailian Platform, Integrating Multiple Large Models Including GLM-5.1

Ping An Insurance's Holding in AIIB Hong Kong Shares Rises to 25.17%

Bank of China fully redeems 50 billion RMB callable perpetual bonds on May 19, 2026

Ping An Chairman Ma Mingzhe Emphasizes Firm Support for Life Insurance Agents

Fairtree Cuts Alibaba Stake by 57.7%, Other Investors Increase Holdings

Huixi Technology Signs Tripartite Strategic Cooperation Agreement with BOC and PICC in Beijing

Ma Mingzhe: Ping An Firmly Focuses on China as First Strategy, Overseas Expansion Possible with AI Advantages

Ping An Holds Annual Shareholders Meeting, CFO Fu Xin Addresses Stock Dip, Affirms Value Will Prevail

Alibaba Cloud Opens Bailian Platform and Launches New Models with Moonshot and Minimax

Alibaba Dissolves Miaoya AI App Team, Focuses on E-commerce AI Strategy

Xiaomi-controlled company fined 1.67 million yuan for anti-money laundering violations

Yuanbao and Ping An Property & Casualty Launch Million Medical Insurance for People with Pre-existing Conditions

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

GCL Global

Micware

Silexion Therapeutics

MicroAlgo

Vida Global

MetaVia

Tradr 2X Long XNDU Daily ETF

399001

000001

000300

ASHR

MCHI

KWEB

The well-known hedge fund Jige Capital predicts that the Chinese stock market is expected to rise by 10% by the end of 2026, benefiting from supportive policies, low valuations, and expectations of a bottoming out in the real estate sector. This judgment is consistent with the predictions of Goldman Sachs and JPMorgan Chase. CEO Stephen Jen pointed out that regulatory policies will boost corporate profits, and the contraction in real estate supply along with a recovery in demand will provide new momentum for the stock market. Additionally, if the conflict in the Middle East calms down, it will create further benefits

腾讯新闻 - 财经

Shenzhen Index

SSE Index

CSI 300

Goldman Sachs

GOLDMAN SACHS GROUP INC DEP SHR REP 1/1000TH PFD SER A

GOLDMAN SACHS GROUP INC DEP SHS REPSTG 1/1000TH PRF SER C

GOLDMAN SACHS GROUP INC DEP REP 1/1000TH PRF D

JPMorgan Chase

Yinhua CSI All Share Investment Banking & Brokerage ETF

Fullgoal CSI 800 Banks ETF

CAM CSI300

Hwabao WP CSI Banks ETF

Hwabao WP CSI All Share Investment Banking & Brokerage ETF

ChinaAMC CSI Banks ETF

Huaan CSI Banks ETF

iShares China Large Cap

Xtrk Hrvt Csi 300 Chn

VanEck China Bond ETF

iShares MSCI China

Krne Csi China Internet

WP CSI Banks ETF

E Fund CNI Value 100 ETF

Guotai CSI All Share Investment Banking & Brokerage ETF

Fortune SG SSE 180 Value ETF

The founder of the "Dollar Smile" latest prediction: China's stock market is about to rise by 10%

LEGN

GPCR

VNET

The SPDR S&P China ETF (GXC) has an implied analyst target price of $124.19, indicating a potential upside of 34.69% from its recent trading price of $92.21. Notable underlying holdings include Legend Biotech Corp (LEG), with a target price of $60.63 (216.78% upside), Structure Therapeutics Inc (GPCR) at $109.00 (103.81% upside), and VNET Group Inc (VNET) at $16.34 (99.55% upside). Analysts' optimism raises questions about the validity of these targets and the need for further investor research.

nasdaq

Legend Biotech

Structure Therapeutics

Vnet

We Did The Math GXC Can Go To $124

512380

CHAU

KALL

China ETFs are gaining traction as a potential safe investment amid rising oil shock fears, particularly due to tensions in the Strait of Hormuz. Funds like the iShares MSCI China ETF and SPDR S&P China ETF are positioned to benefit from China's economic growth and government support. With strong domestic indicators, including a 2.8% rise in retail sales and a 6.3% increase in industrial production, these ETFs may serve as a hedge against global energy disruptions, offering resilience rather than direct resource exposure.

benzinga_article

Yinhua MSCI China A ETF

Direxion CSI 300 China

Kraneshares MSCI All China Index

Oil Shock Curveball: China ETFs Suddenly Look Like The War‑Proof Trade of 2026

159591

CNYA

512550

Qiushi Network published an article stating that to effectively stimulate the vitality of private investment, comprehensive measures must be taken to implement a policy combination. It is necessary to expand investment space, implement a negative list for market access, and eliminate hidden barriers; stimulate endogenous motivation, optimize the business environment, and protect the rights and interests of private enterprises; strengthen factor guarantees, improve financing support for private enterprises, and increase government procurement support for small and medium-sized enterprises; guide investment direction, encourage private capital to invest in emerging fields and technological research and development, and promote industrial upgrading

Wallstreetcn

Fullgoal CSI A50 ETF

ISHRS MSCI China

Harvest FTSE China A50 ETF

Qiushi.net: Effectively Stimulating the Vitality of Private Investment

Invesco S&P China A 300 Swap UCITS ETF reported a net asset value (NAV) per share of USD 6.8512 as of February 24, 2026. The total number of shares in issue is 2,313,020. This information is provided by RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority.

London Stock Exchange

Invesco

REG - IVZ S&P China A 300$ - Net Asset Value(s)

Invesco S&P China A MidCap 500 Swap UCITS ETF reported a net asset value (NAV) per share of USD 9.3303 as of February 24, 2026. The total number of shares in issue is 4,471,370. This information is provided by RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority.

iShares China Large Cap UCITS ETF USD

iShares MSCI China A UCITS ETF

REG - IVZ SP China A 500 $ - Net Asset Value(s)

This article highlights three dividend-focused China ETFs—KWEB, FXI, and GXC—that provide opportunities for income and growth amid geopolitical tensions. These funds allow investors to benefit from China's economic reforms and consumer growth while diversifying away from U.S. equities. The ETFs are noted for their reliable payouts from established companies, making them attractive options for investors seeking steady income streams.

Tip Ranks

3 Best Dividend China ETFs to Watch Now

SPDR S&P China(GXC.US)